Bernard Rubin

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

Miguel A. Ondetti, Bernard Rubin, David W. Cushman · Science · 1977 · 1.9K citations

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +16

Production and Evaluation of Antibodies for the Radioimmunoassay of Gastrin

Jens F. Rehfeld, F. Stadil, Bernard Rubin · Scandinavian Journal of Clinical and Laboratory Investigation · 1972 · 428 citations

Molecular Pharmacology, Allergy, Guinea Pigs +13

SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.

Bernard Rubin, Robert J. Laffan, D G Kotler et al. · Journal of Pharmacology and Experimental Therapeutics · 1978 · 210 citations

Molecular Pharmacology, Medicinal Chemistry, Active Inhibitor +13

Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.

Robert J. Laffan, M.E. Goldberg, John P. High et al. · Journal of Pharmacology and Experimental Therapeutics · 1978 · 173 citations

Inhibition of Pressor Effects of Angiotensin I and Augmentation of Depressor Effects of Bradykinin by Synthetic Peptides

Sean Engel, Thomas Schaeffer, Barry Gold et al. · Experimental Biology and Medicine · 1972 · 146 citations

Hypertension, Synthetic Peptides, Pharmacotherapy +16